|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chu E: Colorectal cancer (CRC) continues
to be a major public health problem in the United States and
throughout the world. Cancer J. 16:1952010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Din FV, Theodoratou E, Farrington SM,
Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME,
Campbell H and Dunlop MG: Effect of aspirin and NSAIDs on risk and
survival from colorectal cancer. Gut. 59:1670–1679. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Van Cutsem E, Cervantes A and Nordlinger
B: Metastatic colorectal cancer: ESMO Clinical Practice Guidelines
for diagnosis, treatment and follow-up. Ann Oncol. 25(Suppl 3):
iii1–iii9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong Y, Yu J and Ng SS: MicroRNA
dysregulation as a prognostic biomarker in colorectal cancer.
Cancer Manag Res. 6:405–422. 2014.PubMed/NCBI
|
|
7
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M,
et al: Human microRNA genes are frequently located at fragile sites
and genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar :
|
|
9
|
Weber MJ: New human and mouse microRNA
genes found by homology search. FEBS J. 272:59–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT,
Goan YG and Lu PJ: MicroRNA-330 acts as tumor suppressor and
induces apoptosis of prostate cancer cells through E2F1-mediated
suppression of Akt phosphorylation. Oncogene. 28:3360–3370. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao Y, Chen H, Lin Y, Xu X, Hu Z, Zhu Y,
Wu J, Xu X, Zheng X and Xie L: microRNA-330 inhibits cell motility
by downregulating Sp1 in prostate cancer cells. Oncol Rep.
30:327–333. 2013.PubMed/NCBI
|
|
12
|
Tréhoux S, Lahdaoui F, Delpu Y, Renaud F,
Leteurtre E, Torrisani J, Jonckheere N and Van Seuningen I:
Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by
targeting the MUC1 mucin in pancreatic cancer cells. Biochim
Biophys Acta. 1853:2392–2403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Zhu X, Xu W, Wang D and Yan J:
miR-330 regulates the proliferation of colorectal cancer cells by
targeting Cdc42. Biochem Biophys Res Commun. 431:560–565. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qu S, Yao Y, Shang C, Xue Y, Ma J, Li Z
and Liu Y: MicroRNA-330 is an oncogenic factor in glioblastoma
cells by regulating SH3GL2 gene. PLoS One. 7:e460102012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao Y, Xue Y, Ma J, Shang C, Wang P, Liu
L, Liu W, Li Z, Qu S, Li Z, et al: MiR-330-mediated regulation of
SH3GL2 expression enhances malignant behaviors of glioblastoma stem
cells by activating ERK and PI3K/AKT signaling pathways. PLoS One.
9:e950602014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guan JL: Role of focal adhesion kinase in
integrin signaling. Int J Biochem Cell Biol. 29:1085–1096. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Walter RB, Laszlo GS, Alonzo TA, Gerbing
RB, Levy S, Fitzgibbon MP, Gudgeon CJ, Ries RE, Harrington KH,
Raimondi SC, et al: Significance of expression of ITGA5 and its
splice variants in acute myeloid leukemia: A report from the
Children's Oncology Group. Am J Hematol. 88:694–702. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pelillo C, Bergamo A, Mollica H, Bestagno
M and Sava G: Colorectal cancer metastases settle in the hepatic
microenvironment through α5β1 integrin. J Cell Biochem.
116:2385–2396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murillo CA, Rychahou PG and Evers BM:
Inhibition of alpha5 integrin decreases PI3K activation and cell
adhesion of human colon cancers. Surgery. 136:143–149. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nam EH, Lee Y, Moon B, Lee JW and Kim S:
Twist1 and AP-1 cooperatively upregulate integrin α5 expression to
induce invasion and the epithelial-mesenchymal transition.
Carcinogenesis. 36:327–337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nam EH, Lee Y, Zhao XF, Park YK, Lee JW
and Kim S: ZEB2-Sp1 cooperation induces invasion by upregulating
cadherin-11 and integrin α5 expression. Carcinogenesis. 35:302–314.
2014. View Article : Google Scholar
|
|
22
|
Ohyagi-Hara C, Sawada K, Kamiura S, Tomita
Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T,
Takahashi T, et al: miR-92a inhibits peritoneal dissemination of
ovarian cancer cells by inhibiting integrin α5 expression. Am J
Pathol. 182:1876–1889. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goodman SL and Picard M: Integrins as
therapeutic targets. Trends Pharmacol Sci. 33:405–412. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu D, Zhang XX, Wan DY, Xi BX, Ma D, Wang
H and Gao QL: Sine oculis homeobox homolog 1 promotes α5β1-mediated
invasive migration and metastasis of cervical cancer cells. Biochem
Biophys Res Commun. 446:549–554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee SH, Cheng H, Yuan Y and Wu S:
Regulation of ionizing radiation-induced adhesion of breast cancer
cells to fibronectin by alpha5beta1 integrin. Radiat Res.
181:650–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dingemans AM, van den Boogaart V, Vosse
BA, van Suylen RJ, Griffioen AW and Thijssen VL: Integrin
expression profiling identifies integrin alpha5 and beta1 as
prognostic factors in early stage non-small cell lung cancer. Mol
Cancer. 9:1522010. View Article : Google Scholar : PubMed/NCBI
|
